EUVIMEDEUVIMED entdecken
Crossref

Gene therapy acceptance in a high-consanguinity sickle cell disease population: bridging genetic literacy to therapeutic innovation in Saudi Arabia

Khaled Essawi

Experimental Hematology · 2026

DOI: 10.1016/j.exphem.2026.105380 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Hematology, 2026. Verfasst von Khaled Essawi. Beteiligte Einrichtung: Department of Medical Laboratory Technology, College of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia. Electronic address: kessa…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Consanguinity, Genetic Therapy. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Jazan University, Ministry of Education - Kingdom of Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Jazan region of Saudi Arabia has a high prevalence of sickle cell disease (SCD), compounded by consanguineous marriages. The Jazan region exemplifies a population that is markedly underrepresented in genomic medicine research, distinguished by distinctive sociocultural factors, including consanguinity rates surpassing one half. Although gene therapy (GT) offers a potential cure, its implementation requires an understanding of local awareness and acceptance. A cross-sectional online survey of 357 Jazan residents, including 104 individuals/families affected with SCD, assessed genetic literacy, clinical burden, and GT attitudes. Multivariate logistic regression identified predictors of GT awareness and acceptance. Despite high genetic literacy (84.0% knew SCD inheritance; 72.5% were aware of consanguinity risks), only 45.4% were aware of GT. Graduate education (odds ratio [OR], 3.54; 95% confidence interval [CI], 1.80-6.95) and personal SCD status (OR, 1.97; 95% CI, 1.15-3.37) independently predicted GT awareness. Among affected individuals, GT acceptance was independently predicted by awareness of consanguinity risk (OR, 3.51; 95% CI, 1.25-9.80) and personal SCD status (OR, 2.89; 95% CI, 1.08-7.74). This educated cohort exhibits a significant gap between genetic knowledge and GT awareness. Acceptance is strongly driven by an understanding of inheritance patterns, highlighting the need for genetic counseling that links consanguinity risks to therapeutic advances to facilitate equitable GT implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellConsanguinityGenetic TherapyHumansSaudi ArabiaFemaleMaleCross-Sectional StudiesAdultHealth Knowledge, Attitudes, PracticeAdolescentYoung Adult

Autor:innen und Institutionen

  • Department of Medical Laboratory Technology, College of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia. Electronic address: kessawi@jazanu.edu.sa.

Förderung

  • Jazan University
  • Ministry of Education - Kingdom of Saudi Arabia

Zitieren

APA

Essawi, K. (2026). Gene therapy acceptance in a high-consanguinity sickle cell disease population: bridging genetic literacy to therapeutic innovation in Saudi Arabia. Experimental Hematology. https://doi.org/10.1016/j.exphem.2026.105380

Vancouver

Essawi K. Gene therapy acceptance in a high-consanguinity sickle cell disease population: bridging genetic literacy to therapeutic innovation in Saudi Arabia. Experimental Hematology. 2026. doi:10.1016/j.exphem.2026.105380

BibTeX
@article{Essawi2026,
  author = {Essawi, Khaled},
  title = {Gene therapy acceptance in a high-consanguinity sickle cell disease population: bridging genetic literacy to therapeutic innovation in Saudi Arabia},
  journal = {Experimental Hematology},
  year = {2026},
  doi = {10.1016/j.exphem.2026.105380}
}
Kostenlos starten →